Sun, Jingjing
The University of Texas MD Anderson Cancer Center
3 papers on CoChatORCID 0000-0002-6230-1015
Most cited papers
- Verified
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer
Gao, J., Ward, J. F., Pettaway, C. A., Shi, L. Z., Subudhi, S. K., Vence, L. M., Zhao, H., Chen, J., Chen, H., Efstathiou, E., et al. (2017) · Nature Medicine
Cancer Immunotherapy and BiomarkersProstate Cancer Treatment and Research
Cited by 594
- Verified
Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
Subudhi, S. K., Aparicio, A., Gao, J., Zurita, A. J., Araujo, J. C., Logothetis, C. J., Tahir, S. A., Korivi, B. R., Slack, R. S., Vence, L., et al. (2016) · Proceedings of the National Academy of Sciences
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 226
- Verified
Increased frequency of ICOS+ CD4 T cells as a pharmacodynamic biomarker for anti-CTLA-4 therapy
Ng Tang, D., Shen, Y., Sun, J., Wen, S., Wolchok, J. D., Yuan, J., Allison, J. P., & Sharma, P. (2013) · Cancer Immunology Research
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 203
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free